Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy

被引:8
作者
Tzivanakis, A. [1 ]
Dayal, S. P. [1 ]
Arnold, S. J. [1 ]
Mohamed, F. [1 ]
Cecil, T. D. [1 ]
Venkatasubramaniam, A. K. [1 ]
Moran, B. J. [1 ]
机构
[1] Basingstoke & North Hampshire Hosp, Peritoneal Malignancy Inst, Basingstoke RG24 9NN, Hants, England
关键词
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PSEUDOMYXOMA PERITONEI; INCISIONAL HERNIA; COMPONENTS SEPARATION; MORBIDITY; DISSEMINATION; MANAGEMENT; CLOSURE; RISK;
D O I
10.1002/bjs5.93
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients with peritoneal malignancy often have multiple laparotomies before referral for cytoreductive surgery (CRS). Some have substantial abdominal wall herniation and tumour infiltration of abdominal incisions. CRS involves complete macroscopic tumour removal and hyperthermic intraperitoneal chemotherapy (HIPEC). Abdominal wall reconstruction is problematic in these patients. The aim of this study was to establish immediate and long-term outcomes of abdominal wall reconstruction with biological mesh in a single centre. Methods: A dedicated peritoneal malignancy database was searched for all patients who had biological mesh abdominal wall reconstruction between 2004 and 2015. Short- and long-term outcomes were reviewed. All patients had annual abdominal CT as routine peritoneal malignancy follow-up. Results: Some 33 patients (22 women) with a mean age of 53.4 (range 19-82) years underwent abdominal wall reconstruction with biological mesh. The majority (23) had CRS for pseudomyxoma (19 low grade), six for colorectal peritoneal metastasis and four for appendiceal adenocarcinoma; 18 had undergone CRS and HIPEC previously. Twenty-five of the 33 patients had abdominal wall tumour involvement and eight had concurrent hernias. The mean duration of surgery was 486 (range 120-795) min and the mean mesh size used was 345 (50-654) cm(2). Ten patients developed wound infections and four had a seroma. Two developed early enterocutaneous fistulas. Mean follow-up was 48 months. Five patients developed an incisional hernia. Four died from progressive malignancy. A further 15 patients had disease recurrence, but only one had isolated abdominal wall recurrence. Conclusion: Biological mesh was safe and effective for abdominal wall reconstruction in peritoneal malignancy. Postoperative wound infections were frequent but nevertheless incisional hernia rates were low with no instances of mesh-related bowel erosion or fistulation.
引用
收藏
页码:464 / 469
页数:6
相关论文
共 30 条
[1]   The Effects of Adjuvant Experimental Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy on Intestinal and Abdominal Healing after Cytoreductive Surgery for Peritoneal Carcinomatosis in the Rat [J].
Aarts, F. ;
Bleichrodt, R. P. ;
de Man, B. ;
Lomme, R. ;
Boerman, O. C. ;
Hendriks, T. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) :3299-3307
[2]   Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines [J].
Adachi, Satoko ;
Kokura, Satoshi ;
Okayama, Tetsuya ;
Ishikawa, Takeshi ;
Takagi, Tomohisa ;
Handa, Osamu ;
Naito, Yuji ;
Yoshikawa, Toshikazu .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2009, 25 (03) :210-219
[3]   Initial UK experience with transversus abdominis muscle release for posterior components separation in abdominal wall reconstruction of large or complex ventral hernias: a combined approach by general and plastic surgeons [J].
Appleton, N. D. ;
Anderson, K. D. ;
Hancock, K. ;
Scott, M. H. ;
Walsh, C. J. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2017, 99 (04) :265-270
[4]   Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy [J].
Boutros, Cherif ;
Somasundar, Ponandai ;
Espat, N. Joseph .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
[5]   Surgical treatment of incisional hernia [J].
Cassar, K ;
Munro, A .
BRITISH JOURNAL OF SURGERY, 2002, 89 (05) :534-545
[6]   Outcome of reconstructive surgery for intestinal fistula in the open abdomen [J].
Connolly, Patrick T. ;
Teubner, Antje ;
Lees, Nicholas P. ;
Anderson, Iain D. ;
Scott, Nigel A. ;
Carlson, Gordon L. .
ANNALS OF SURGERY, 2008, 247 (03) :440-444
[7]   Complete Cytoreduction for Pseudomyxoma Peritonei Is Optimal but Maximal Tumor Debulking May Be Beneficial in Patients in Whom Complete Tumor Removal Cannot Be Achieved [J].
Dayal, Sanjeev ;
Taflampas, Panagiotis ;
Riss, Stefan ;
Chandrakumaran, Kandiah ;
Cecil, Thomas D. ;
Mohamed, Faheez ;
Moran, Brendan J. .
DISEASES OF THE COLON & RECTUM, 2013, 56 (12) :1366-1372
[8]   Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial [J].
Deerenberg, Eva B. ;
Harlaar, Joris J. ;
Steyerberg, Ewout W. ;
Lont, Harold E. ;
van Doorn, Helena C. ;
Heisterkamp, Joos ;
Wijnhoven, Bas P. L. ;
Schouten, Willem R. ;
Cense, Huib A. ;
Stockmann, Hein B. A. C. ;
Berends, Frits J. ;
Dijkhuizen, F. Paul H. L. J. ;
Dwarkasing, Roy S. ;
Jairam, An P. ;
van Ramshorst, Gabrielle H. ;
Kleinrensink, Gert-Jan ;
Jeekel, Johannes ;
Lange, Johan F. .
LANCET, 2015, 386 (10000) :1254-1260
[9]   Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases [J].
Elias, D. ;
Goere, D. ;
Dumont, F. ;
Honore, C. ;
Dartigues, P. ;
Stoclin, A. ;
Malka, D. ;
Boige, V. ;
Ducreux, M. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) :332-340
[10]   Incisional hernia rate 3 years after midline laparotomy [J].
Fink, C. ;
Baumann, P. ;
Wente, M. N. ;
Knebel, P. ;
Bruckner, T. ;
Ulrich, A. ;
Werner, J. ;
Buechler, M. W. ;
Diener, M. K. .
BRITISH JOURNAL OF SURGERY, 2014, 101 (02) :51-54